Fundraising FoxCancer Focus — Full Portfolio
11 tracked investments · listed companies and verified rows first
Mereo BioPharma is a biopharmaceutical company publicly traded on Nasdaq under the ticker MREO.
BiotechHealthtechLondon, GB
John Richard(Head of Corporate Development and Co-Founder)inCharles Sermon(General Counsel and Co-Founder)Richard Jones(Chief Financial Officer)inJill Henrich(Senior Vice President)inDenise Scots-Knight(Chief Executive Officer)in
BoardDr. Deepa Pakianathan(Non-Executive Director)
Co-investorsPontifax Venture CapitalVivo CapitalWoodford Investment Management
Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms.
BiotechDeep TechMedical Devices
Co-investorsPeregrine VenturesIsrael Biotech Fund
ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company developing immune therapies for immune-excluded tumors, which resist standard PD-1 blockade.
BiotechHealthtechMedical DevicesDoylestown, US
Michael A. Curran(Director)inJennifer Barlow(Executive Officer, Director)Clifford Stocks(Director)James Barlow(Executive Officer, Director)Jeremy Barton(Executive Officer)Federica O'Brien(Executive Officer)
Co-investors3Spoke CapitalAdit Ventures Management, LlcAngel Physicians FundBioAdvanceService Provider CapitalTexas HALO Fund
Netherlands-based developer of fully synthetic immune therapies against cancer and persistent viral infections using a synthetic long peptide platform.
Co-investorsInvest-NLRegeneron Ventures
Uses proprietary technology to unmask cancer and recruit a targeted immune response.
Co-investorsaMoonPeregrine Ventures
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.
BiotechMedical DevicesHouston, US
Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)
BoardThomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)
Co-investorsMission Biocapital4BIO CapitalCancer FundFitz Gate VenturesModi VenturesPortal Innovations+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Southeast Venture HoldingsEisbach BioMolecular ImagingNectin TherapeuticsStarget Pharma
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.